ZOMANEX

Zomanex is a specialty pharmaceutical company dedicated to the development of proprietary pharmaceutical products based on its patented Orazom drug delivery platform. Orazom allows hydrophobic compounds to be efficiently absorbed in the small intestine, thereby permitting oral dosing of pharmaceutical compounds that have previously required iv or injectable administration. Orazom 3907, the Company’s lead product opportunity, is an application of Orazom to Paclitaxel, an effective and off-patent cancer chemotherapeutic agent.